[76] Bruix J, Castells A, Bosch J, et al. Surgical
resection of hepatocellular carcinoma in cirrhotic patients: prognostic value
of preoperative portal pressure[J]. Gastroenterology, 1996, 111(4): 1018-22. [77] Cescon M, Colecchia A, Cucchetti A, et al. Value
of transient elastography measured with FibroScan in predicting the outcome of
hepatic resection for hepatocellular carcinoma[J]. Ann Surg, 2012, 256(5):
706-12; discussion 12-3. [78] Shen Y, Zhou C, Zhu G, et al. Liver Stiffness
Assessed by Shear Wave Elastography Predicts Postoperative Liver Failure in
Patients with Hepatocellular Carcinoma[J]. J Gastrointest Surg, 2017, 21(9):
1471-9. [79] Rajakannu M, Cherqui D, Ciacio O, et al. Liver
stiffness measurement by transient elastography predicts late posthepatectomy
outcomes in patients undergoing resection for hepatocellular carcinoma[J].
Surgery, 2017, 162(4): 766-74. [80] Zhong JH, Ke Y, Gong WF, et al. Hepatic resection
associated with good survival for selected patients with intermediate and
advanced-stage hepatocellular carcinoma[J]. Ann Surg, 2014, 260(2): 329-40. [81] Xiao H, Zhang B, Mei B, et al. Hepatic resection
for hepatocellular carcinoma in patients with portal hypertension: a long-term
benefit compared with transarterial chemoembolization and thermal ablation[J].
Medicine (Baltimore), 2015, 94(7): e495. [82] Bosch J, Abraldes JG, Berzigotti A, et al. The
clinical use of HVPG measurements in chronic liver disease[J]. Nat Rev
Gastroenterol Hepatol, 2009, 6(10):573-82. [83] Chen X, Zhai J, Cai X, et al. Severity of portal
hypertension and prediction of postoperative liver failure after liver
resection in patients with Child-Pugh grade A cirrhosis[J]. Br J Surg, 2012,
99(12): 1701-10. [84] Chen MS, Li JQ, Zheng Y, et al. A prospective
randomized trial comparing percutaneous local ablative therapy and partial
hepatectomy for small hepatocellular carcinoma[J]. Ann Surg, 2006, 243(3):
321-8. [85] Kudo M, Hasegawa K, Kawaguchi Y, et al. A
multicenter randomized controlled trial to evaluate the efficacy of surgery
versus radiofrequency ablation for small hepatocellular carcinoma (SURF trial):
Analysis of overall survival[J]. Journal of Clinical Oncology, 2021,
39(15_suppl): 4093-. [86] Mohkam K, Dumont PN, Manichon AF, et al. No-touch
multibipolar radiofrequency ablation vs. surgical resection for solitary
hepatocellular carcinoma ranging from 2 to 5cm[J]. J Hepatol, 2018, 68(6):
1172-80. [87] Xu XL, Liu XD, Liang M, et al. Radiofrequency
Ablation versus Hepatic Resection for Small Hepatocellular Carcinoma:
Systematic Review of Randomized Controlled Trials with Meta-Analysis and Trial
Sequential Analysis[J]. Radiology, 2018, 287(2): 461-72. [88] Liu PH, Hsu CY, Hsia CY, et al. Surgical
Resection Versus Radiofrequency Ablation for Single Hepatocellular Carcinoma ≤
2 cm in a Propensity Score Model[J]. Ann Surg, 2016, 263(3): 538-45. [89] Feng K, Yan J, Li X, et al. A randomized
controlled trial of radiofrequency ablation and surgical resection in the
treatment of small hepatocellular carcinoma[J]. J Hepatol, 2012, 57(4):
794-802. [90] Xu Q, Kobayashi S, Ye X, et al. Comparison of hepatic
resection and radiofrequency ablation for small hepatocellular carcinoma: a
meta-analysis of 16,103 patients[J]. Sci Rep, 2014, 4: 7252. [91] Xia Y, Li J, Liu G, et al. Long-term Effects of
Repeat Hepatectomy vs Percutaneous Radiofrequency Ablation Among Patients With
Recurrent Hepatocellular Carcinoma: A Randomized Clinical Trial[J]. JAMA Oncol,
2020, 6(2):255-63. [92] Yin L, Li H, Li AJ, et al. Partial hepatectomy
vs. transcatheter arterial chemoembolization for resectable multiple
hepatocellular carcinoma beyond Milan Criteria: a RCT[J]. J Hepatol, 2014,
61(1): 82-8. [93] Torzilli G, Belghiti J, Kokudo N, et al. A
snapshot of the effective indications and results of surgery for hepatocellular
carcinoma in tertiary referral centers: is it adherent to the EASL/AASLD
recommendations?: an observational study of the HCC East-West study group[J].
Ann Surg, 2013, 257(5): 929-37. [94] Wang K, Guo WX, Chen MS, et al. Multimodality
Treatment for Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Large-Scale,
Multicenter, Propensity Mathching Score Analysis[J].
Medicine (Baltimore), 2016, 95(11): e3015. [95] Wei X, Jiang Y, Zhang X, et al. Neoadjuvant
Three-Dimensional Conformal Radiotherapy for Resectable Hepatocellular
Carcinoma With Portal Vein Tumor Thrombus: A Randomized, Open-Label,
Multicenter Controlled Study[J]. J Clin Oncol, 2019: Jco1802184. [96] Li XL, Zhu XD, Cai H, et al. Postoperative
alpha-fetoprotein response predicts tumor recurrence and survival after
hepatectomy for hepatocellular carcinoma: A propensity score matching
analysis[J]. Surgery, 2019, 165(6): 1161-7. [97] Yang J, Tao HS, Cai W, et al. Accuracy of actual
resected liver volume in anatomical liver resections guided by 3-dimensional
parenchymal staining using fusion indocyanine green fluorescence imaging[J]. J
Surg Oncol, 2018, 118(7):1081-7. [98] Mise Y, Hasegawa K, Satou S, et al. How Has
Virtual Hepatectomy Changed the Practice of Liver Surgery?: Experience of 1194
Virtual Hepatectomy Before Liver Resection and Living Donor Liver
Transplantation[J]. Ann Surg, 2018, 268(1):127-33. [99] 中华医学会数字医学分会, 中国研究型医院学会数字智能化外科专业委员会, 中国医师协会肝癌专业委员会, 等. 计算机辅助联合吲哚菁绿分子荧光影像技术在肝脏肿瘤诊断和手术导航中应用指南(2019 版)[J]. 中国实用外科杂志, 2019, 39(7): 641-50,54. [100] Jiang HT, Cao JY. Impact of laparoscopic versus
open hepatectomy on perioperative clinical outcomes of patients with primary
hepatic carcinoma[J]. Chin Med Sci J, 2015, 30(2): 80-3. [101] 中国研究型医院学会肝胆胰外科专业委员会. 腹腔镜肝切除术治疗肝细胞癌中国专家共识(2020 版)[J]. 中华消化外科杂志, 2020, 19(11): 1119-34. [102] Wang X, Teh CSC, Ishizawa T, et al. Consensus
Guidelines for the Use of Fluorescence Imaging in Hepatobiliary Surgery[J]. Ann
Surg, 2021, 274(1): 97-106. [103] 夏永祥, 张峰, 李相成, 等. 原发性肝癌 10 966 例外科治疗分析[J]. 中华外科杂志, 2021, 59（1）: 6-17. [104] Hidaka M, Eguchi S, Okuda K, et al. Impact of
Anatomical Resection for Hepatocellular Carcinoma With Microportal Invasion
(vp1): A Multi-institutional Study by the Kyushu Study Group of Liver
Surgery[J]. Ann Surg, 2020, 271(2): 339-46. [105] Zhong FP, Zhang YJ, Liu Y, et al. Prognostic
impact of surgical margin in patients with epatocellular carcinoma: A
meta-analysis[J]. Medicine (Baltimore), 2017, 96(37): e8043. [106] Shi M, Guo RP, Lin XJ, et al. Partial
hepatectomy with wide versus narrow resection margin for solitary hepatocellular
carcinoma: a prospective randomizedtrial[J]. Ann Surg, 2007, 245(1): 36-43. [107] Yang P, Si A, Yang J, et al. A wide-margin liver
resection improves long-term outcomes for patients with HBV-related
hepatocellular carcinoma with microvascular invasion[J]. Surgery, 2019, 165(4):
721-30. [108] Liu CL, Fan ST, Lo CM, et al. Anterior approach
for major right hepatic resection for large hepatocellular carcinoma[J]. Ann
Surg, 2000, 232(1): 25-31. [109] Zhou C, Peng Y, Zhou K, et al. Surgical
resection plus radiofrequency ablation for the treatment of multifocal
hepatocellular carcinoma[J]. Hepatobiliary Surg Nutr, 2019, 8(1): 19-28. [110] Zhang ZM, Lai EC, Zhang C, et al. The strategies
for treating primary hepatocellular carcinoma with portal vein tumor thrombus[J].
Int J Surg, 2015, 20:8-16. [111] Fu SY, Lau WY, Li AJ, et al. Liver resection
under total vascular exclusion with or without preceding Pringle manoeuvre[J].
Br J Surg, 2010, 97(1): 50-5. [112] Satoh S, Ikai I, Honda G, et al.
Clinicopathologic evaluation of hepatocellular carcinoma with bile duct
thrombi[J]. Surgery, 2000, 128(5): 779-83.
|
